Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing KeyGen Biotech is a high-tech enterprise focused on the development and manufacturing of life science research reagents and diagnostic tools. The company provides an extensive portfolio of products, including apoptosis detection kits, protein extraction reagents, and high-quality antibodies used in molecular and cellular biology research. In addition to its product catalog, KeyGen offers comprehensive contract research services (CRO) such as cell line development, proteomics, and drug screening platforms. Based in Nanjing, China, the company serves as a significant supplier for both academic institutions and biopharmaceutical companies globally, specializing in tools for cancer research and signal transduction studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KeyGen Biotech.